Skip to content

Clinical trials

Breast Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Czechia Clear all

166 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20034
20044
20053
200610
20076
20087
200912
20108
20118
20127
20135
201410
20158
20164
20175
20186
20197
20205
20217
20228
20237
20242
202513
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Active, not recruiting22
Recruiting14
Terminated14
Approved for marketing1
Withdrawn1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche21
AstraZeneca19
Novartis Pharmaceuticals19
Pfizer13
Eli Lilly and Company7
Sanofi7
Bayer5
Amgen4
GlaxoSmithKline4
Genentech, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms166
Neoplasms20
Neoplasm Metastasis17
Prostatic Neoplasms9
Multiple Myeloma5
Recurrence5
Colorectal Neoplasms4
Ovarian Neoplasms4
Triple Negative Breast Neoplasms4
Breast Diseases3

Trials

Showing 76 to 100 of 166. Each trial links to its page on Pharma Observatory.

66 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.